These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10469377)

  • 1. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis.
    Boaz M; Matas Z; Biro A; Katzir Z; Green M; Fainaru M; Smetana S
    Kidney Int; 1999 Sep; 56(3):1078-83. PubMed ID: 10469377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients.
    Boaz M; Matas Z; Biro A; Katzir Z; Green M; Fainaru M; Smetana S
    Am J Kidney Dis; 1999 Sep; 34(3):438-44. PubMed ID: 10469853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.
    Dirican M; Sarandol E; Serdar Z; Ocak N; Dilek K
    Clin Nephrol; 2007 Sep; 68(3):144-50. PubMed ID: 17915616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
    El-Mesallamy HO; Abdel Hamid SG; Gad MZ
    Kidney Blood Press Res; 2008; 31(3):189-95. PubMed ID: 18511874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and cardiovascular disease in dialyzed patients.
    Usberti M; Gerardi GM; Gazzotti RM; Benedini S; Archetti S; Sugherini L; Valentini M; Tira P; Bufano G; Albertini A; Di Lorenzo D
    Nephron; 2002 May; 91(1):25-33. PubMed ID: 12021516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Malondialdehyde-Modified Low-Density Lipoprotein as a Risk Marker for Peripheral Arterial Stiffness in Maintenance Hemodialysis Patients.
    Liu WN; Hsu YC; Lu CW; Lin SC; Wu TJ; Lin GM
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792880
    [No Abstract]   [Full Text] [Related]  

  • 8. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
    As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
    Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.
    Hou JS; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG; Tsai JP
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients.
    Asamiya Y; Yajima A; Tsuruta Y; Otsubo S; Nitta K
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):619-27. PubMed ID: 22608251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of novel risk factors for cardiovascular disease between hemodialysis patients with and without protein-energy wasting.
    Tabibi H; As'habi A; Mahdavi-Mazdeh M; Hedayati M; Nozary-Heshmati B
    Int Urol Nephrol; 2014 Oct; 46(10):2015-20. PubMed ID: 24906424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between cardiovascular complication and inflammation, oxidative stress of patient with maintenance hemodialysis].
    Zuo C; Qiu HY; Li Z; Xie XS; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):119-21, 129. PubMed ID: 18390217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsCRP, sICAM-1 and TAFI in hemodialysis patients: linking inflammation and hypofibrinolysis to cardiovascular events.
    Gad MZ; El-Mesallamy HO; Sanad EF
    Kidney Blood Press Res; 2008; 31(6):391-7. PubMed ID: 19052466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.